Life Biosciences

About Life Biosciences

Life Biosciences is a biotechnology company focused on pioneering cellular rejuvenation through partial epigenetic reprogramming to reverse and prevent age-related diseases. Their mission is to address debilitating age-related conditions by rejuvenating cells to a healthier state.

Products & Services

Partial Epigenetic Reprogramming Platform:A technology that rejuvenates aged and injured cells to restore cellular function, with potential therapeutic applications in a wide range of age-related diseases.

ER-100 for Optic Neuropathies:A therapeutic candidate under development for optic neuropathies, with FDA clearance for IND application announced.

Specialties

Cellular Rejuvenation Partial Epigenetic Reprogramming Age-Related Disease Treatment Optic Neuropathies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 80000000 MR: - FA: $80 million FAN: 80000000	D: 2026-04-08 FD: 2026-04-08	-

Series D Latest

2026-04-08

$80.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tristan Edwards

Co-Founder

D

David Sinclair

Chairman & Co-Founder

D

David A. Sinclair

Professor in the Department of Genetics at Harvard Medical School

J

Jerry McLaughlin

Chief Executive Officer

D

David R. Guyer

Director

S

Stuart Gibson

Director

View 10 more team members with Pro

Unlock Full Team Directory

Recent News